Skip to search formSkip to main contentSkip to account menu

AH 23848

Known as: 4-Heptenoic acid, 7-(5-((1,1'-biphenyl)-4-ylmethoxy)-2-(4-morpholinyl)-3-oxocyclopentyl)-, (1alpha(Z),2beta,5alpha)-(+-)-, AH-23848, AH23848 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Oxidative stress is implicated in the pathogenesis of many inflammatory pulmonary diseases, including cystic fibrosis (CF… 
2010
2010
To investigate the expression of four subtypes of E‐series prostaglandin (EP1–EP4) receptors and the urodynamic effects of an EP4… 
2010
2010
The up-regulation of adhesion molecule expressions on monocytes enhances cell-to-cell interactions with T cells, leading to… 
2009
2009
Background  Prokineticins 1 and 2 (PROK1 and PROK2) are so named because they contract gastrointestinal smooth muscle, yet little… 
1991
1991
Young, genetically hypertensive Lyon (LH) rats exhibited an increased renal in vivo turnover ofnorepinephrine and an elevated… 
1991
1991
The effects of prostaglandin F2 alpha, prostaglandin E1, prostaglandin E2 and the thromboxane A2 analogue U46619 were determined… 
1990
1990
Abstract— Dose‐response curves were obtained to bolus injections of noradrenaline (NA) and 5‐hydroxytryptamine (5‐HT) in blood… 
1989
1989
AH23848 is a potent thromboxane A2-receptor blocker inhibiting platelet aggregation in vitro and in vivo. Oral administration to… 
1986
1986
1 Arachidonic acid (AA, 0.125‐2.0 mg kg−1) administered intravenously to male Wistar rats produced a dose‐dependent fall in…